Table 1 Immunologic laboratory values at time of diagnosis of patients with TOP2B mutationsa
From: Mutations in topoisomerase IIβ result in a B cell immunodeficiency
Family 1 | Family 2 | Family 3 | ||
|---|---|---|---|---|
Age at presentation | 7 years | 35 years | 6 years | 5 years |
General immune evaluation | ||||
Leukocytes (cells/μL) | 5200 | 7600 | 7000 | 5900 |
[4500–13500] | [4000–1000] | [5500–15,000] | [5500–15,000] | |
Absolute Lymphocyte count (cells/μL) | 1900 | 2000 | 2240 | 3547 |
[1500–6500] | [1200–3500] | [1500–7000] | [1500–7000] | |
CD3+ T cells (cells/μL) | 1853 | 1764 | 2720 | 3422 |
[1200–2700] | [1100–2500] | [1900–3000] | [1400–3700] | |
CD4+ T cells (cells/μL) | 1122 | 1008 | 1728 | 1832 |
[800–1500] | [700–1400] | [570–1200] | [700–2200] | |
CD8+ T cells (cells/μL) | 774 | 726 | 800 | 1417 |
[400–1200] | [400–1100] | [475–960] | [490–1300] | |
CD19+ B cells (cells/μL) | 0 | 48 | 0 | 0 |
[150–600] | [150–500] | [200–600] | [200–600] | |
CD16+ NK cells (cells/μL) | 58 | 172 | 448 | 17 |
[200–400] | [150–400] | [200–600] | [200–600] | |
CH50 | n.d. | n.d. | 90 | >65 |
[n.a.] | [n.a.] | [>80] | [>60] | |
B cell-specific immune evaluation | ||||
Total IgG (mg/dL) | 232 | 631 | 73 | 242 |
[610–1480] | [720–1460] | [400–1075] | [463–1236] | |
IgA (mg/dL) | <26 | 158 | 33 | 7 |
[40–290] | [24–381] | [19–119] | [25–154] | |
IgM (mg/dL) | 150 | 128 | 12 | <6 |
[380–1860] | [54–227] | [25–114] | [43–196] | |
IgE (mg/dL) | n.d. | n.d. | 5 | n.d. |
[n.a.] | [n.a.] | [0–450] | [n.a.] | |
tetanus titerb (IU/mL) | deficient | n.d. | <0.04–> 0.11 | 0.1 |
[>0.15] | [n.a.] | [>0.15] | [>0.15] | |
Diphtheria (IU/mL) titers | deficient | n.d. | undetectable | <0.1 |
[>0.15] | [n.a.] | [>0.15] | [>0.15] | |
H. influenzae B titers (ng/mL) | deficient | n.d. | undetectable | <0.15 |
[>0.15] | [n.a.] | [>100] | [>0.15] | |
Mitogen stimulation | normal | normal | normal | normal |